iRadimed (NASDAQ:IRMD) is a medical device company specializing in the design, manufacture and distribution of infusion systems and accessories engineered specifically for use in magnetic resonance imaging (MRI) environments. The company’s products enable a wide range of MRI-guided diagnostic and therapeutic procedures by delivering precise, uninterrupted intravenous fluids, contrast agents and medications directly to patients during imaging studies. By addressing the unique safety and electromagnetic compatibility requirements of MRI suites, iRadimed’s offerings help hospitals and outpatient imaging centers optimize workflow and improve patient care.
The company’s flagship product line, known as TRIM, includes MRI-compatible infusion pumps that feature nonferromagnetic construction and low-interference electronics. These pumps are complemented by a suite of ancillary devices such as dual-syringe modules, MRI-safe infusion sets and monitoring accessories designed to integrate seamlessly with existing imaging equipment. iRadimed also provides comprehensive technical support, training and maintenance services to ensure that clinical teams can operate its systems effectively and in compliance with regulatory standards.
Founded in the late 1990s, iRadimed has grown from a niche supplier of specialized pumps into a recognized leader in MRI infusion technology. The company holds multiple patents covering its core pump mechanisms and control systems, and it maintains quality management certification under international medical device regulations. With manufacturing facilities located in central Florida, iRadimed oversees all stages of product development in-house, from research and prototyping to final assembly and distribution.
iRadimed serves customers across North America, Europe, Asia-Pacific and select emerging markets through a combination of direct sales and a global network of distribution partners. The company is led by President and Chief Executive Officer Euan S. Thomson, who brings extensive experience in medical device innovation and business development. Under Thomson’s leadership, iRadimed continues to invest in new product enhancements and strategic collaborations to expand its footprint in the diagnostic imaging sector.
